Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Leishen Energy Holding Co., Ltd. - Ordinary Shares (NQ:LSE)

5.350 UNCHANGED
Streaming Delayed Price Updated: 3:56 PM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Leishen Energy Holding Co., Ltd. - Ordinary Shares

< Previous 1 2 3 Next >
HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma
From HUTCHMED (China) Limited
Via GlobeNewswire
Caledonia Mining Corporation Plc: Short delay to the publication of financial results for the year ended December 31, 2024
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Here are the top movers in Thursday's session.
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill
Unusual volume stocks in Thursday's session
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill
Top movers in Thursday's session
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
Which stocks are gapping on Thursday?
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Intended Retirement of Independent Non-executive Directors and changes of composition of board committees
From HUTCHMED (China) Limited
Via GlobeNewswire
HUTCHMED Highlights Savolitinib SAVANNAH Phase II and Other Data at European Lung Cancer Congress 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
Stay updated with the stocks that are on the move in today's after-hours session.
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
Nasdaq Gains Over 1%; Williams-Sonoma Shares Plunge After Q4 Results
Via Benzinga
HUTCHMED Reports 2024 Full Year Results and Provides Business Updates
65% oncology products revenue growth drove profitable operation and supported new ATTC platform 
From HUTCHMED (China) Limited
Via GlobeNewswire
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nexxen Expands U.S. Partnership with Tubi to U.K.
Strategic partnership enhances advertiser engagement and monetisation in the growing U.K. streaming market 
From Nexxen International Ltd.
Via GlobeNewswire
HUTCHMED and Innovent Jointly Announce that the FRUSICA-2 Phase II/III Study of Fruquintinib and Sintilimab Combination Has Met its Primary Endpoint in Advanced Renal Cell Carcinoma in China
From HUTCHMED (China) Limited
Via GlobeNewswire
Executive Appointments Strengthen Nexxen’s Data, Streaming and Omnichannel Expertise
Strategic leadership hires enhance the company’s U.S. regional and global growth as well as its commitment to clients 
From Nexxen International Ltd.
Via GlobeNewswire
Caledonia Mining Corporation Plc: Notice of Results and Investor Presentation
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference
From AVACTA GROUP PLC
Via GlobeNewswire
Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts
Encouraging Progression Free Survival (PFS) data observed in patients with salivary gland cancers compared to conventional treatments 
From AVACTA GROUP PLC
Via GlobeNewswire
HUTCHMED Announces that it has Completed Enrollment of a Phase II Registration Study of Fanregratinib (HMPL-453) for Intrahepatic Cholangiocarcinoma in China
From HUTCHMED (China) Limited
Via GlobeNewswire
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
From HUTCHMED (China) Limited
Via GlobeNewswire
HUTCHMED to Announce 2024 Final Results
From HUTCHMED (China) Limited
Via GlobeNewswire
Caledonia Mining Corporation Plc: Appointment of New Chief Financial Officer
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Leishen Energy Holding Co., Ltd. Announces Fiscal Year 2024 Financial Results Highlighting Strong Operating Cash Flow and Stable Gross Margins
From Leishen Energy Holding Co., Ltd.
Via GlobeNewswire
Caledonia Mining Corporation Plc: Appointments of Stefan Buys and Lesley Goldwasser as Non-Executive Directors
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Metals & Mining Virtual Investor Conference Agenda Announced for February 12th and 13th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
From HOOKIPA Pharma Inc.
Via GlobeNewswire
Nexxen Fuels Growth with Live Sports Offerings and Key Partnerships, Reaching Highly Engaged Audiences Across Channels
By collaborating with publisher partners and DSPs, Nexxen saw an increase in spend on live sports packages, including a 315% increase from StackAdapt campaigns 
From Nexxen International Ltd.
Via GlobeNewswire
Caledonia Mining Corporation Plc: Blanket Mine Q4 and FY 2024 Production and 2025 Guidance
Blanket production meets guidance; continued investment in growth and efficiency 
From Caledonia Mining Corporation Plc
Via GlobeNewswire
HUTCHMED Announces NMPA Full Approval for ORPATHYS® (savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC
From HUTCHMED (China) Limited
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.